|
|
|
Insider
Information: |
Hallal David |
Relationship: |
Director |
City: |
Cheshire |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
2,978,651 |
|
Indirect Shares
|
17,647,006 |
|
|
Direct
Value |
$38,642,476 |
|
|
Indirect Value
|
$34,321,195 |
|
|
Total
Shares |
20,625,657 |
|
|
Total
Value |
$72,963,670 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-113.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexion Pharmaceuticals Inc |
ALXN |
CEO, Director |
2016-08-08 |
189,266 |
2014-12-18 |
113,122 |
Premium* |
|
Scholar Rock Holding Corp |
SRRK |
Director |
2019-09-18 |
290,595 |
2019-09-18 |
0 |
Premium* |
|
Allovir Inc |
ALVR |
|
2024-06-06 |
2,143,662 |
2024-06-06 |
17,533,884 |
Premium* |
|
Seer, Inc. |
SEER |
|
2024-06-12 |
355,128 |
|
0 |
Premium* |
|
Iteos Therapeutics, Inc. |
ITOS |
Director |
2022-06-09 |
0 |
2021-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
129 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-03-02 |
4 |
S |
$51.80 |
$518,000 |
D/D |
(10,000) |
7,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-07-12 |
4 |
S |
$51.91 |
$12,355 |
D/D |
(238) |
6,616 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-06-21 |
4 |
S |
$54.81 |
$50,206 |
D/D |
(916) |
6,854 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP. Global Commercial Ops |
|
2011-07-27 |
4 |
S |
$57.27 |
$31,785 |
D/D |
(555) |
29,735 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP. Global Commercial Ops |
|
2011-07-28 |
4 |
S |
$57.33 |
$2,113,872 |
D/D |
(36,872) |
29,735 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2011-11-28 |
4 |
S |
$66.59 |
$1,331,800 |
D/D |
(20,000) |
39,735 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-11-04 |
4 |
S |
$70.29 |
$1,405,800 |
D/D |
(20,000) |
3,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-11-03 |
4 |
S |
$70.42 |
$184,446 |
D/D |
(2,619) |
3,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2012-01-27 |
4 |
S |
$74.41 |
$41,223 |
D/D |
(554) |
41,645 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2012-01-30 |
4 |
S |
$74.51 |
$141,271 |
D/D |
(1,896) |
39,749 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2012-01-10 |
4 |
S |
$75.00 |
$40,200 |
D/D |
(536) |
42,199 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-12-15 |
4 |
S |
$79.33 |
$1,080,157 |
D/D |
(13,616) |
8,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2011-01-10 |
4 |
S |
$81.27 |
$21,862 |
D/D |
(269) |
11,001 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2011-01-18 |
4 |
S |
$82.66 |
$20,252 |
D/D |
(245) |
10,756 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commerical Ops |
|
2011-01-27 |
4 |
S |
$84.70 |
$94,017 |
D/D |
(1,110) |
9,646 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2012-02-23 |
4 |
S |
$85.50 |
$3,420,000 |
D/D |
(40,000) |
53,210 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2012-06-15 |
4 |
S |
$93.67 |
$1,340,230 |
D/D |
(14,308) |
63,210 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Commercial Ops |
|
2013-01-29 |
4 |
S |
$94.32 |
$48,292 |
D/D |
(512) |
71,331 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Commercial Ops |
|
2013-01-28 |
4 |
S |
$94.50 |
$59,724 |
D/D |
(632) |
71,843 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-02-04 |
4 |
S |
$95.68 |
$200,537 |
D/D |
(2,085) |
69,246 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2011-03-03 |
4 |
S |
$99.21 |
$486,129 |
D/D |
(4,900) |
15,646 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2011-03-02 |
4 |
S |
$100.00 |
$10,000 |
D/D |
(100) |
15,646 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP. Global Commercial Ops |
|
2012-07-31 |
4 |
S |
$104.99 |
$71,393 |
D/D |
(680) |
61,975 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP. Global Commercial Ops |
|
2012-07-27 |
4 |
S |
$106.14 |
$5,445,908 |
D/D |
(50,555) |
62,655 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-07-30 |
4 |
S |
$110.86 |
$82,702 |
D/D |
(746) |
88,908 |
0 |
- |
|
129 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|